219 related articles for article (PubMed ID: 23982880)
21. Quantitative assessment of the association between XRCC3 C18607T polymorphism and glioma risk.
Wang R; Li M; Gao WW; Gu Y; Guo Y; Wang G; Tian HL
Tumour Biol; 2014 Feb; 35(2):1101-5. PubMed ID: 24186073
[TBL] [Abstract][Full Text] [Related]
22. XRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysis.
Chen X; Wang Z; Yan Y; Li P; Yang Z; Qin L; Mo W
PLoS One; 2014; 9(1):e84195. PubMed ID: 24454720
[TBL] [Abstract][Full Text] [Related]
23. Lack of influence of an XRCC3 gene polymorphism on oral cancer susceptibility: meta-analysis.
Zhang EJ; Cui ZG; Xu ZF; Duan WY; Huang SH; Tan XX; Yin ZH; Sun CF; Lu L
Asian Pac J Cancer Prev; 2014; 15(23):10329-34. PubMed ID: 25556470
[TBL] [Abstract][Full Text] [Related]
24. Association between the XRCC3 Thr241Met polymorphism and cervical cancer risk: a meta-analysis.
Qin LY; Chen X; Li P; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6703-7. PubMed ID: 24377592
[TBL] [Abstract][Full Text] [Related]
25. Significant association between XRCC3 C241T polymorphism and increased risk of hepatocellular carcinoma: a meta-analysis.
Wu D; Jiang H; Yu H; Xu D; Liang J; Jin J
Tumour Biol; 2013 Dec; 34(6):3865-9. PubMed ID: 23873110
[TBL] [Abstract][Full Text] [Related]
26. Contribution of DNA double-strand break repair gene XRCC3 genotypes to oral cancer susceptibility in Taiwan.
Tsai CW; Chang WS; Liu JC; Tsai MH; Lin CC; Bau DT
Anticancer Res; 2014 Jun; 34(6):2951-6. PubMed ID: 24922659
[TBL] [Abstract][Full Text] [Related]
27. No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.
Xu YH; Gu LP; Sun YJ; Cheng BJ; Lu S
Tumour Biol; 2013 Apr; 34(2):865-74. PubMed ID: 23300009
[TBL] [Abstract][Full Text] [Related]
28. Association between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies.
Chai F; Liang Y; Chen L; Zhang F; Jiang J
Med Sci Monit; 2015 Oct; 21():3231-40. PubMed ID: 26498491
[TBL] [Abstract][Full Text] [Related]
29. Contribution of DNA Double-strand Break Repair Gene XRCC3 Genotypes to Triple-negative Breast Cancer Risk.
Su CH; Chang WS; Hu PS; Hsiao CL; Ji HX; Liao CH; Yueh TC; Chuang CL; Tsai CW; Hsu CM; Lane HY; Bau DT
Cancer Genomics Proteomics; 2015; 12(6):359-67. PubMed ID: 26543082
[TBL] [Abstract][Full Text] [Related]
30. Analyzing association of the XRCC3 gene polymorphism with ovarian cancer risk.
Yuan C; Liu X; Yan S; Wang C; Kong B
Biomed Res Int; 2014; 2014():648137. PubMed ID: 25006581
[TBL] [Abstract][Full Text] [Related]
31. Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma.
Yan L; Li Q; Li X; Ji H; Zhang L
Cell Physiol Biochem; 2016; 38(3):1075-84. PubMed ID: 26938431
[TBL] [Abstract][Full Text] [Related]
32. XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis.
Zhan P; Wang Q; Qian Q; Yu LK
J Exp Clin Cancer Res; 2013 Jan; 32(1):1. PubMed ID: 23289442
[TBL] [Abstract][Full Text] [Related]
33. Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies.
Huang G; Cai S; Wang W; Zhang Q; Liu A
PLoS One; 2013; 8(8):e68457. PubMed ID: 23990873
[TBL] [Abstract][Full Text] [Related]
34. Association between XRCC3 rs861539 Polymorphism and the Risk of Ovarian Cancer: Meta-Analysis and Trial Sequential Analysis.
Hu S; Jing Y; Liu F; Han F
Biomed Res Int; 2022; 2022():3915402. PubMed ID: 35978646
[TBL] [Abstract][Full Text] [Related]
35. XRCC3 T241M polymorphism and lung cancer risk in the Han Chinese population: a meta-analysis.
Zhang JH; Wen QL; Yang C; Li AL; Liu Y; Li XS
Genet Mol Res; 2014 Nov; 13(4):9505-13. PubMed ID: 25501160
[TBL] [Abstract][Full Text] [Related]
36. Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies.
He XF; Wei W; Li JL; Shen XL; Ding DP; Wang SL; Liu ZZ; Qin JB; Wu LX; Xie DL
Gene; 2013 Jul; 523(1):10-9. PubMed ID: 23562721
[TBL] [Abstract][Full Text] [Related]
37. Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.
He XF; Wei W; Su J; Yang ZX; Liu Y; Zhang Y; Ding DP; Wang W
Mol Biol Rep; 2012 May; 39(5):5125-34. PubMed ID: 22161248
[TBL] [Abstract][Full Text] [Related]
38. Contribution of X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 3 (XRCC3) Genotype to Leiomyoma Risk.
Chang WS; Tsai CW; Wang JY; Ying TH; Hsiao TS; Chuang CL; Yueh TC; Liao CH; Hsu CM; Liu SP; Gong CL; Tsai CH; Bau DT
Anticancer Res; 2015 Sep; 35(9):4691-6. PubMed ID: 26254358
[TBL] [Abstract][Full Text] [Related]
39. Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk.
Wang Z; Zhang W
Tumour Biol; 2013 Jun; 34(3):1421-9. PubMed ID: 23504553
[TBL] [Abstract][Full Text] [Related]
40. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis.
Zhu J; Hua RX; Jiang J; Zhao LQ; Sun X; Luan J; Lang Y; Sun Y; Shang K; Peng S; Ma J
PLoS One; 2014; 9(5):e97616. PubMed ID: 24841208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
